Stocks To Buy/Sell Today, Aug 12: Top Picks By Chandan Taparia of MOFSL For Profitable Trading On Tuesday

Amid positive global cues triggered by Asian markets, which are mostly trading in green, after Trump extends the China tariff deadline by 90 days, and Dow futures are currently trading with gains of 0.11% (48 points up), the Indian stock market is expected to open on a flat to slightly positive note, according to Gift Nifty trends, which is trading 48 points higher (+0.2%), as global market sentiment improved in the wake of reports that US-Russia peace talks are expected to take place this week and Indian investors welcomed FII inflows of Rs1,933cr on Friday.

Nifty Outlook Today

"Nifty immediate support is at 24350 then 24250 zones while resistance at 24650 then 24800 zones. Now it has to hold above 24442 zones for an up move towards 24650 then 24800 zones while supports can be seen at 24350 then 24250 zones," commented Chandan Taparia of Motilal Oswal Securities.

Bank Nifty Outlook Today

"Bank Nifty support is at 55250 then 55000 zones while resistance at 55750 then 56000 zones. Now it has to cross and hold above 55555 zones for a bounce towards 55750 then 56000 levels while a hold below the same could see some weakness towards 55250 then 55000 zones," Chandan Taparia stated.

Stocks To Buy Today

On Tuesday, August 12, Chandan Taparia of Motilal Oswal Securities recommended buying or selling these stocks.

ETERNAL

CMP: Rs 309, stop-loss: Rs 297, target: Rs 330, Duration: Weekly, Recommendation: Buy

• Bullish "Pole & Flag" pattern.
• Strong bullish candle.
• Hovering around "All Time High" zones.
• Respecting 20 DEMA support zones.
• Surge in buying volumes.
• RSI indicator positively placed.
• We recommend to buy the stock at CMP Rs 309 with a SL of Rs 297 and a TGT of Rs 330.

Lemon Tree

CMP Rs 142, Target: Rs 185, 30% Upside, Buy

• Lemon Tree Hotels (LEMONTRE) reported healthy revenue growth of 18% YoY in 1QFY26, led by a significant improvement in the occupancy rate (OR) to 72.5% (up 590bp YoY) and healthy growth in the average room rate (ARR) to INR6,236 (up 10% YoY).
• Operating leverage led to a 160bp YoY expansion in EBITDA margin despite renovation-related expenses.
• LEMONTRE maintained a healthy growth momentum in 1QFY26, and we expect this trend to continue through FY26.
• Growth will be supported by the ramp-up of Aurika Mumbai (~72% occupancy in 1Q, expected ~80% in FY26), favorable demand-supply conditions, renovation-led improvements in ARR and occupancy, the upgraded Infinity 2.0 loyalty program (2.1m members with 45% repeat business), and retail demand initiatives (which contributed ~45% of 1QFY25 room revenue).
• We expect LEMONTRE to post a CAGR of 13%/16%/34% in revenue/EBITDA/adj. PAT over FY25-27, with RoCE improving to ~18% by FY27 from ~11.7% in FY25.

Nippon Life India AMC

CMP Rs 806, Target Rs 930, 15% Upside, Buy

• Nippon Life India AMC (NAM) ranks among the top 10 AMCs, demonstrating the fastest QAAUM growth with a 27% YoY increase to INR6.1t as of Jun'25. This growth has boosted its overall market share to 8.5%, marking a rise of 23bp QoQ (the highest since Jun'19). The performance was supported by consistent net inflows, strong SIP traction, and a healthy equity mix (46.9% as of Jun'25).
• It is scaling its alternatives and offshore businesses, with INR81b in AIF commitments and INR166b in offshore AUM. These segments serve as incremental growth levers beyond the core MF franchise.
• NAM is strategically scaling its Specialized Investment Fund (SIF) platform as a high-potential, standalone business focused on differentiated, alpha-generating strategies. Backed by a dedicated team and strong management commitment, the SIF vertical is being positioned as a key long-term growth engine.
• NAM reported blended yields of 36bp in 1QFY26 (equity: 55bp). Around 45% of its equity AUM has undergone pricing resets. Management expects a gradual annual decline of ~2-3bp due to telescopic pricing adjustments but aims to offset this impact through diversified retail flows, SIP growth, and product innovation. We project a 14%/16%/15% CAGR in revenue/EBITDA/PAT over FY25-27E.

Quant Intraday Sell Ideas For The Day

• AMBUJACEM (Sell): Close Price - Rs 588.9, SL (1%) - Rs 594.7, Target: Rs 583.0
• SAIL (Sell): Close Price - Rs 121.7, SL (1%) - Rs 122.9, Target: Rs 120.5

Disclaimer

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.